Daniel C. Butler
Lund, M 22242, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Re-defining granulomas: bacterial effectors, host circuits, and spatially resolved immunity.
Journal: Journal of leukocyte biology
Published: December 13, 2025
Therapeutic Effects of IL-1RA against Acute Bacterial Infections, including Antibiotic-Resistant Strains.
Journal: Pathogens (Basel, Switzerland)
Published: December 07, 2023
Immunomodulation therapy offers new molecular strategies to treat UTI.
Journal: Nature reviews. Urology
Published: April 22, 2022
Immunomodulation-A Molecular Solution to Treating Patients with Severe Bladder Pain Syndrome?
Journal: European urology open science
Published: July 07, 2021
Molecular determinants of disease severity in urinary tract infection.
Journal: Nature reviews. Urology
Published: May 07, 2021
Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex.
Journal: Nature communications
Published: April 08, 2020
Bladder cancer therapy without toxicity-A dose-escalation study of alpha1-oleate.
Journal: International journal of cancer
Published: January 29, 2020
A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer.
Journal: Nature biotechnology
Published: August 27, 2019
Fimbriae reprogram host gene expression - Divergent effects of P and type 1 fimbriae.
Journal: PLoS pathogens
Published: January 04, 2019
Neuroepithelial control of mucosal inflammation in acute cystitis.
Journal: Scientific reports
Published: December 01, 2017
Triggered Urine Interleukin-6 Correlates to Severity of Symptoms in Nonfebrile Lower Urinary Tract Infections.
Journal: The Journal of urology
Published: January 26, 2017
Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.
Journal: PLoS pathogens
Published: April 22, 2016
Last Updated: 09/26/2026